Contraceptive Market Research Report by Drugs (Contraceptive Injectable, Emergency Contraceptive Pills, Oral Contraceptives, and Transdermal Patches), by Gender (Female Contraceptive Devices and Male Contraceptive Devices), by Distribution - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Contraceptive Market is expected to grow from USD 43,827.88 Million in 2020 to USD 101,758.61 Million by the end of 2025. 2. The Global Contraceptive Market is expected to grow from EUR 38,429.12 Million in 2020 to EUR 89,223.88 Million by the end of 2025. 3. The Global Contraceptive Market is expected to grow from GBP 34,163.57 Million in 2020 to GBP 79,320.23 Million by the end of 2025. 4. The Global Contraceptive Market is expected to grow from JPY 4,677,545.79 Million in 2020 to JPY 10,860,223.06 Million by the end of 2025. 5. The Global Contraceptive Market is expected to grow from AUD 63,643.91 Million in 2020 to AUD 147,767.04 Million by the end of 2025.
Market Segmentation & Coverage: This research report categorizes the Contraceptive to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Drugs, the Contraceptive Market studied across Contraceptive Injectable, Emergency Contraceptive Pills, Oral Contraceptives, and Transdermal Patches.
Based on Gender, the Contraceptive Market studied across Female Contraceptive Devices and Male Contraceptive Devices.
Based on Distribution, the Contraceptive Market studied across Clinics, Hospital Pharmacy, Independent Pharmacy, and Online Platform.
Based on Geography, the Contraceptive Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles: The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Contraceptive Market including Agile Therapeutics, Allergan Plc, Ani Pharmaceuticals Inc., Bayer Corporation, Church & Dwight Co., Inc., CooperSurgical, Inc., Fuji Latex Co. Ltd, Gilead Sciences Inc., Johnson & Johnson, Mayer Laboratories, Inc., Merck & Co. Inc., Pfizer Inc, Reckitt Benckiser Group Plc, Teva Pharmaceuticals Industries Ltd., and Veru Inc..
Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch™ FPNV Positioning Matrix: The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Contraceptive Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch™ Competitive Strategic Window: The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as: 1. What is the market size and forecast of the Global Contraceptive Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Contraceptive Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Contraceptive Market? 4. What is the competitive strategic window for opportunities in the Global Contraceptive Market? 5. What are the technology trends and regulatory frameworks in the Global Contraceptive Market? 6. What are the modes and strategic moves considered suitable for entering the Global Contraceptive Market?
Our reports have been used by over 10K customers, including:
125 pages •
By Euromonitor International
• Dec 2020
2020 has proven to be a fairly turbulent year for consumer health in Germany following the emergence of the pandemic. After the ‘’hamster’’ (stockpiling purchases) period in March due to various lockdown restrictions by the government in an effort to curb the spread of the virus, it was followed by a slump, with the market subsequently entering...
92 pages •
By Euromonitor International
• Nov 2020
Consumer health is expected to see moderate current value growth in 2020, partially benefitting from the COVID-19 health crisis. The virus created changes in purchasing habits for many consumers who feared falling ill. This led to stockpiling analgesics at the start of the outbreak and generally increased demand of immunity boosting products...
90 pages •
By Euromonitor International
• Nov 2020
COVID-19 will have a significant effect on current value sales growth in consumer health during 2020, but the impact will not be uniformly negative. Wound care will be particularly badly affected, as people are spending less time on the move and out of doors due to restrictions introduced to curb the spread of the virus. As a result, they...
116 pages •
By Euromonitor International
• Nov 2020
Consumer health in the United Arab Emirates is set to record a positive performance in 2020, with the outbreak of the COVID-19 pandemic contributing as one of the major reasons for the growth. However, overall demand for many categories is set to be more subdued after initial stockpiling during lockdown in Q1 considering the recessionary macroeconomic...
106 pages •
By Euromonitor International
• Nov 2020
Overall consumer health is expected to see a slightly slower current value growth rate in 2020 than seen in any other year of the review period. Although this is due to the COVID-19 outbreak in the country, categories are being impacted in very different ways. Consumer behaviour and spending on consumer health products have changed significantly...
Over the Counter Drugs Market Report Overview Over the Counter Drugs market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Over the Counter Drugs market types and applications. It is a focused study on Over the Counter Drugs market space...
The global blister packaging market reached a value of US$ 21.3 Billion in 2020. Blister packaging refers to a pre-formed plastic packaging which comprises of a cavity that is made using a thermoformed plastic and a paper or aluminum foil back. This type of packaging displays a large part of the content to consumers while protecting it from...
119 pages •
By Euromonitor International
• Jan 2021
COVID-19 had a significant impact on consumer health in Austria in 2020 with it resulting in consumers reassessing their priorities and focusing on their immediate concerns. As concerns rose about the threat posed by COVID-19 many households started stocking up on products that were perceived to treat the symptoms of the virus, such as analgesics...
Global Over the Counter (OTC) Drugs Market, By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements (VMS), Other), By Dosage Form (Tablets, Capsules, Powders, Ointments, Liquids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Other), By Region, Forecast...
90 pages •
By Euromonitor International
• Nov 2020
Consumer health is expected to see slightly higher current value growth in 2020 than was seen in 2019, with COVID-19 expected to be one of the main factors dictating growth in Uruguay. While the COVID-19 outbreak in Uruguay had little impact in terms of infections and deaths due to the country’s good healthcare system, locals’ concern about...
OTC
Dietary Supplement
Healthcare
Vitamin
Uruguay
World
Analgesic Medicine Sales
Vitamin Sales
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.